Download PDF
Pharmacopsychiatry 2006; 39(4): 160
DOI: 10.1055/s-2006-947212
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

In Vitro Toxicity of Clozapine, Olanzapine, and Quetiapine on Granulocyte-Macrophage Progenitors (GM-CFU)

Pharmacopsychiatry 2006; 39: 20-22A. Pessina1 , E. Turlizzi1 , A. Bonomi1 , F. Guizzardi1 , L. Cavicchini1 , C. Croera2 , S. Bareggi3
  • 1Institute of Microbiology, University of Milan, Italy
  • 2ECVAM, Institute for Health and Consumer Protection, European Commission Joint Research Centre, Ispra, Italy
  • 3Department of Pharmacology, University of Milan, Italy
Further Information

Publication History

Publication Date:
27 July 2006 (online)

Also available at
 PDF Download Permissions and Reprints
Table of Contents

    Correction to:

    In Vitro Toxicity of Clozapine, Olanzapine, and Quetiapine on Granulocyte-Macrophage Progenitors (GM-CFU)Pharmacopsychiatry 2006; 39(01): 20-22
    DOI: 10.1055/s-2006-931475

    A. Pessina, E. Turlizzi, A. Bonomi, F. Guizzardi, L. Cavicchini, C. Croera, S. Bareggi. In Vitro Toxicity of Clozapine, Olanzapine, and Quetiapine on Granulocyte-Macrophage Progenitors (GM-CFU). Pharmacopsychiatry 2006; 39: 20-22

    On page 22, lines 27-32 the correct sentence should be as follow:

    In the case of olanzapine, our data strongly support the hypothesis that the serum concentrations found in patients (54.2 μg/l + 37.8) by Bergemann et al. [2] are not enough to inhibit myeloid progenitors in vitro (concentration of 7.26-13.43 μg/ml), as do the growing number of reports suggesting that olanzapine toxicity leads to both thrombocytopenia and severe agranulocytosis [3, 14, 23, 24].

       Permissions and Reprints